Skip to main content
Erschienen in: Pathology & Oncology Research 2/2020

27.06.2019 | Original Article

Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma

verfasst von: Abbas Mohammadpour-Gharehbagh, Zahra Heidari, Moein Eskandari, Abtin Aryan, Saeedeh Salimi

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Evidence suggests that the microRNAs are involved in tumorigenesis and progression of various types of malignant tumors. Therefore, the aim of current research was to examine association between genetic variants in the miRNA machinery genes and risk of papillary thyroid carcinoma(PTC) in Iranian population. Peripheral blood samples were collected from 120 PTC patients and 130 healthy subjects. Genotyping of polymorphisms in miRNA Machinery genes (DICER1 rs3742330, DROSHA rs6877842 and XPO5 rs11077) polymorphisms was performed using PCR-RFLP method. Chi square and independent sample t tests were applied for categorical and continuous variables, respectively. In this study, we found that frequency of DICER1 rs3742330G allele was significantly higher in controls compared to PTC patients. In addition, the DICER1 rs3742330 polymorphism was associated with lower risk of PTC in dominant (AG + GG vs. AA, OR = 0.5, 95%CI = 0.3–0.9, P = 0.03) model. No association was found between DROSHA rs6877842 and XPO5 rs11077 polymorphisms and PTC neither in dominant nor in recessive and allelic models. The frequency of DROSHA rs6877842GC genotype was higher in PTC patients with smaller tumor size (<1). Therefore, this polymorphism could be a protective factor for tumor development in PTC patients (OR = 0.3, 95%CI = 0.1–1, P = 0. 04). The current study indicated that DICER1 rs3742330 polymorphism was associated with lower risk of PTC. Furthermore, DROSHA rs6877842 polymorphism could be a protective factor for tumor development in PTC patients.
Literatur
1.
Zurück zum Zitat Ries LAG, Young Jr JL, Keel GE, Eisner MP, Lin YD, Horner M-JD (2007) Cancer survival among adults: US SEER program, 1988–2001. Patient and tumor characteristics SEER Survival Monograph Publication:07–6215 Ries LAG, Young Jr JL, Keel GE, Eisner MP, Lin YD, Horner M-JD (2007) Cancer survival among adults: US SEER program, 1988–2001. Patient and tumor characteristics SEER Survival Monograph Publication:07–6215
2.
Zurück zum Zitat Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. Jama 317(13):1338–1348CrossRef Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. Jama 317(13):1338–1348CrossRef
3.
Zurück zum Zitat Ning L, Rao W, Yu Y, Liu X, Pan Y, Ma Y, Liu R, Zhang S, Sun H, Yu Q (2016) Association between the KRAS gene polymorphisms and papillary thyroid carcinoma in a Chinese Han population. J Cancer 7(15):2420–2426CrossRef Ning L, Rao W, Yu Y, Liu X, Pan Y, Ma Y, Liu R, Zhang S, Sun H, Yu Q (2016) Association between the KRAS gene polymorphisms and papillary thyroid carcinoma in a Chinese Han population. J Cancer 7(15):2420–2426CrossRef
4.
Zurück zum Zitat Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148(3):396–402CrossRef Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148(3):396–402CrossRef
5.
Zurück zum Zitat Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P (2010) Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 162(4):763–770CrossRef Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P (2010) Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 162(4):763–770CrossRef
6.
Zurück zum Zitat Zhang Q, Song F, Zheng H, Zhu X, Song F, Yao X, Zhang L, Chen K (2013) Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population. Thyroid 23(1):38–44CrossRef Zhang Q, Song F, Zheng H, Zhu X, Song F, Yao X, Zhang L, Chen K (2013) Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population. Thyroid 23(1):38–44CrossRef
8.
Zurück zum Zitat Wei W-J, Lu Z-W, Li D-S, Wang Y, Zhu Y-X, Wang Z-Y, Wu Y, Wang Y-L, Ji Q-H (2014) Association of the miR-149 Rs2292832 polymorphism with papillary thyroid Cancer risk and clinicopathologic characteristics in a Chinese population. Int J Mol Sci 15(11):20968–20981CrossRef Wei W-J, Lu Z-W, Li D-S, Wang Y, Zhu Y-X, Wang Z-Y, Wu Y, Wang Y-L, Ji Q-H (2014) Association of the miR-149 Rs2292832 polymorphism with papillary thyroid Cancer risk and clinicopathologic characteristics in a Chinese population. Int J Mol Sci 15(11):20968–20981CrossRef
9.
Zurück zum Zitat Heidari Z, Mohammadpour-Gharehbagh A, Eskandari M, Harati-Sadegh M, Salimi S (2018) Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features. J Cell Biochem 120:8640–8647. https://doi.org/10.1002/jcb.28152 CrossRef Heidari Z, Mohammadpour-Gharehbagh A, Eskandari M, Harati-Sadegh M, Salimi S (2018) Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features. J Cell Biochem 120:8640–8647. https://​doi.​org/​10.​1002/​jcb.​28152 CrossRef
10.
Zurück zum Zitat Ha T-Y (2011) MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11(3):135–154CrossRef Ha T-Y (2011) MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11(3):135–154CrossRef
11.
Zurück zum Zitat Zhang W, Dahlberg JE, Tam W (2007) MicroRNAs in tumorigenesis: a primer. Am J Pathol 171(3):728–738CrossRef Zhang W, Dahlberg JE, Tam W (2007) MicroRNAs in tumorigenesis: a primer. Am J Pathol 171(3):728–738CrossRef
12.
Zurück zum Zitat Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15(6):321–333CrossRef Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15(6):321–333CrossRef
13.
Zurück zum Zitat Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610CrossRef Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610CrossRef
16.
Zurück zum Zitat Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610CrossRef Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610CrossRef
18.
Zurück zum Zitat Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, Choi DH, Kim JH, Kim NK (2013) Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause 20(10):1067–1073CrossRef Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, Choi DH, Kim JH, Kim NK (2013) Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause 20(10):1067–1073CrossRef
20.
Zurück zum Zitat Li D, Jian W, Wei C, Song H, Gu Y, Luo Y, Fang L (2014) Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int J Clin Exp Pathol 7(11):7672–7680PubMedPubMedCentral Li D, Jian W, Wei C, Song H, Gu Y, Luo Y, Fang L (2014) Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int J Clin Exp Pathol 7(11):7672–7680PubMedPubMedCentral
21.
Zurück zum Zitat Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang X, Fan Y (2015) MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cell Physiol Biochem: international journal of experimental cellular physiology, biochemistry, and pharmacology 35(1):71–82. https://doi.org/10.1159/000369676 CrossRef Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang X, Fan Y (2015) MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cell Physiol Biochem: international journal of experimental cellular physiology, biochemistry, and pharmacology 35(1):71–82. https://​doi.​org/​10.​1159/​000369676 CrossRef
24.
Zurück zum Zitat Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96(2):111–115CrossRef Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96(2):111–115CrossRef
25.
Zurück zum Zitat Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng J-F, Nick AM (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359(25):2641–2650CrossRef Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng J-F, Nick AM (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359(25):2641–2650CrossRef
26.
Zurück zum Zitat Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R (2014) Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery 156(6):1342–1350CrossRef Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R (2014) Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery 156(6):1342–1350CrossRef
28.
Zurück zum Zitat Osuch-Wojcikiewicz E, Bruzgielewicz A, Niemczyk K, Sieniawska-Buccella O, Nowak A, Walczak A, Majsterek I (2015) Association of polymorphic variants of miRNA processing genes with larynx cancer risk in a polish population. Biomed Res Int 2015(2015):1–17. https://doi.org/10.1155/2015/298378 CrossRef Osuch-Wojcikiewicz E, Bruzgielewicz A, Niemczyk K, Sieniawska-Buccella O, Nowak A, Walczak A, Majsterek I (2015) Association of polymorphic variants of miRNA processing genes with larynx cancer risk in a polish population. Biomed Res Int 2015(2015):1–17. https://​doi.​org/​10.​1155/​2015/​298378 CrossRef
30.
Zurück zum Zitat Leaderer D, Hoffman AE, Zheng T, Fu A, Weidhaas J, Paranjape T, Zhu Y (2011) Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. Int J Mol Epidemiol Genet 2(1):9–18PubMed Leaderer D, Hoffman AE, Zheng T, Fu A, Weidhaas J, Paranjape T, Zhu Y (2011) Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. Int J Mol Epidemiol Genet 2(1):9–18PubMed
31.
Zurück zum Zitat Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res 1(6):460–469CrossRef Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res 1(6):460–469CrossRef
33.
Zurück zum Zitat Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415–419CrossRef Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415–419CrossRef
Metadaten
Titel
Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma
verfasst von
Abbas Mohammadpour-Gharehbagh
Zahra Heidari
Moein Eskandari
Abtin Aryan
Saeedeh Salimi
Publikationsdatum
27.06.2019
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2020
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00688-z

Weitere Artikel der Ausgabe 2/2020

Pathology & Oncology Research 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.